Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We do expect -- we're seeing clinical efficiencies improve and we expect within -- probably within the next two years to three years that we will be in that low to mid-range teens as far as margins are concerned |
| Overall, we had a very successful fourth quarter and year |
| You've done a really good job bringing the margins up in that business |
| You guys are continuing to deliver a really impressive margin in the inpatient rehab business despite what looks like a fairly aggressive development strategy |
| In the fourth quarter of 2023, adjusted EBITDA grew 21% and revenue grew by 5% with all four of our operating divisions again exceeding prior year revenue and EBITDA |
| Our critical illness recovery hospital division continued to see margin improvement in Q4 with a 28% increase in adjusted EBITDA margin along with a 4% reduction in their salary, wages and benefits to revenue ratio compared to the prior year |
| So they have a lot of levers that they can press, and I think that they enjoy solid margins |
| We anticipate that our inpatient rehab division will continue their strong performance and have a successful 2024 |
| But the rehab is a good opportunity |
| Concentra continued their strong performance exceeding prior year revenue, EBITDA and patient volumes |
| But both inpatient rehab and Concentra continues to do quite well both in terms of revenue growth and EBITDA growth |
| This quarter, our outpatient rehab division generated a 41% increase in adjusted EBITDA and an 11% increase in visits per day |
| And what we've seen over the history of the company is these partnership deals and returns and growth within the partnerships is absolutely compelling |
| So we're pretty excited to have Concentra, as you know, all these years that we've had it, and I'm pretty enthusiastic about their prospects as a standalone company |
| We experienced double-digit adjusted EBITDA growth over prior year in every quarter of this year |
| We've experienced very nice volume increases thus far in the first quarter of 2024 and are now at levels that exceed prior year |
| The reduction in labor costs contributed to the improvement of our EBITDA margin with a 4% reduction in our salary, wages and benefit to revenue ratio |
| Our inpatient rehab hospital division experienced 9% increase in net revenue and a 19% increase in adjusted EBITDA |
| And so these opportunities just are really compelling |
| As you pointed out, we are a pretty -- we feel pretty good about the development pipeline for inpatient rehab given our strategy |
| Concentra is doing quite well |
| Overall, I am pleased with the development results and pipeline for our Specialty Hospital divisions |
| While our occupancy was down from same quarter last year, an increase in our case mix index and favorable payer contract negotiations contributed to an increase in our revenue per patient day |
| The outpatient division adjusted EBITDA increased by 40.9% compared to prior year with a 33% increase in EBITDA margin to 7.5% from 5.7% |
| The pipeline for future growth remains strong with 19 executed leases for de novo clinics, of which 10 are scheduled to open in the first half of 2024 |
| Obviously, the inpatient rehab is doing quite well |
| Concentra's adjusted EBITDA margin increased to 15.5% for the quarter compared to 15% for the same quarter prior year |
| Thus far in 2024, our SW&B as a percentage to revenue has continued to trend favorably and we expect to finish at or below 55% in Q1 |
| I mean, we are trying to give a little bit more disclosure, and for us to give how the first quarter is shaping up is, as you know, probably a little unusual for us, but we were pleased that volumes are up |
| We think we're seeing PRN actually increase, which is a good thing |
| Statement |
|---|
| And so -- and this has been part of our efforts with CMS, is that the high-cost outlier increase of the threshold actually hurts those providers that are actually taking care of the very patients that the policy wants the LTACs to take care of |
| As I mentioned before, we did have the cuts from Medicare, and that muted the growth there |
| Although we have fought some reimbursement headwinds in the critical illness, and this high cost outlier threshold issue that we've talked about is certainly a headwind |
| We did have some headwinds, though, in the -- both our critical illness recovery hospitals with regards to the high-cost outlier, and we had cuts on the Medicare portion of our outpatient rehab |
| Nursing sign-on incentive bonus dollars decreased 36% from prior year Q4 and 5% from the prior sequential quarter |
| RN agency utilization decreased throughout the quarter from 14.4% in October, 13.8% in November and 13% in December |
| I know that there's -- obviously there's been some headwinds with Medicare, too, but you guys have been chopping some wood operationally as well over the last, I think, four quarters to six quarters |
| Orientation hours decreased 10% compared to prior year Q4 and decreased 26% compared to Q3 of 2023 |
| So I think you can expect that the critical illness recovery hospitals and outpatient rehab was a little bit muted because of that |
| Nursing sign-on and incentive bonuses dollars also decreased by 5% and we had a 26% decrease in orientation hours |
| And historically we've been in that 15% to 18% as far as agency nursing, and we're down to 13%, 14% |
| Overall, our salaries, wages, and benefits as a percentage of revenue decreased from 59.8% in Q4 prior year, down to 57.6% this past quarter |
| Thinking about outpatient rehab for a second and the revenue per visit and I know the pressure there from Medicare |
| And then, I guess the improvement that you made in the Q4 on the labor side of things happened with volume being a little bit weak |
| Critical illness incurred $3.6 million of startup losses related to new hospitals in this quarter compared to $3.1 million in the same quarter prior year |
| Both nursing agency rates and utilization decreased 24% when compared to prior year Q4 |
| That's not to say that rehab hospitals will not have headwinds in the future |
| Our year-to-date basis with regards to SW&B as a percentage of revenue decreased from 63.4% in '22 down to 57.2% in '23 |
| But at the same time, you have to appreciate that the more high-cost outliers that you hit, the more of the losses you're going to sustain |
| The reductions realized were 17% in RN agency costs, a drop in RN utilization from 15% to 14%, and a decrease in agency rate from $78 to $70 |
Please consider a small donation if you think this website provides you with relevant information